These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1
534 results:

  • 1. Allogeneic transplantation for adult T-cell leukemia/lymphoma in adolescent and young adults and young patients: A nationwide retrospective study by the ATL working group of the Japan society for transplantation and cellular therapy.
    Itonaga H; Fukushima T; Kato K; Nakano N; Kato T; Tanaka T; Eto T; Mori Y; Kawakita T; Uchida N; Fujioka M; Nakamae H; Ogata M; Morishima S; Fukuda T; Kanda Y; Atsuta Y; Fuji S; Yoshimitsu M
    Hematol Oncol; 2024 Nov; 42(6):e3315. PubMed ID: 39367543
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Increasing prostate cancer radiosensitivity by miR-7-5p knockdown of anti-apoptotic genes.
    Darvish L; Bahreyni-Toossi MT; Aghaee-Bakhtiari SH; Akbari-Naserkiadeh A; Vaziri-Nezamdoust F; Azimian H
    Gene; 2025 Jan; 933():148951. PubMed ID: 39303820
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study.
    Al-Sawaf O; Robrecht S; Zhang C; Olivieri S; Chang YM; Fink AM; Tausch E; Schneider C; Ritgen M; Kreuzer KA; Sivchev L; Niemann CU; Schwarer A; Loscertales J; Weinkove R; Strumberg D; Kilfoyle A; Manzoor BS; Jawaid D; Emechebe N; Devine J; Boyer M; Runkel ED; Eichhorst B; Stilgenbauer S; Jiang Y; Hallek M; Fischer K
    Blood; 2024 Oct; 144(18):1924-1935. PubMed ID: 39082668
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Peripheral Blood and Bone Marrow Findings in Treatment-Naive Patients With Cytopenia(s)/Myeloid Neoplasms Harboring Both a Germline and a Somatic DDX41 Mutation.
    Bruehl FK; Elbaz Younes I; Bosler DS; Kelemen K; Jiang L; Reichard KK
    Appl Immunohistochem Mol Morphol; 2024 Sep; 32(8):371-381. PubMed ID: 39046192
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Real-world effectiveness of first-line azacitidine or decitabine with or without venetoclax in acute myeloid leukemia patients unfit for intensive therapy.
    Acker F; Chromik J; Tiedjen E; Wolf S; Vischedyk JB; Makowka P; Enßle JC; Kouidri K; Sebastian M; Steffen B; Oellerich T; Serve H; Neubauer A; Schäfer JA; Bittenbring JT
    Eur J Haematol; 2024 Nov; 113(5):623-630. PubMed ID: 39023132
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. S1P Signaling Genes as Prominent Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic Myeloid leukemia.
    Morang S; Bisht M; Upadhyay V; Thapliyal S; Handu S
    OMICS; 2024 Jul; 28(7):367-376. PubMed ID: 38986084
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. TCL1A-expressing B cells are critical for tertiary lymphoid structure formation and the prognosis of oral squamous cell carcinoma.
    Xie W; Lu J; Chen Y; Wang X; Lu H; Li Q; Jin N; He J; Ou L; Ni J; Shen Y; Shao L
    J Transl Med; 2024 May; 22(1):477. PubMed ID: 38764038
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study.
    Ravandi F; Subklewe M; Walter RB; Vachhani P; Ossenkoppele G; Buecklein V; Döhner H; Jongen-Lavrencic M; Baldus CD; Fransecky L; Pardee TS; Kantarjian H; Yen PK; Mukundan L; Panwar B; Yago MR; Agarwal S; Khaldoyanidi SK; Stein A
    Leuk Lymphoma; 2024 Sep; 65(9):1281-1291. PubMed ID: 38712673
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Ye Y; Labopin M; Gérard S; Yakoub-Agha I; Blau IW; Aljurf M; Forcade E; Gedde-Dahl T; Burns D; Vydra J; Halahleh K; Hamladji RM; Bazarbachi A; Nagler A; Brissot E; Li L; Luo Y; Zhao Y; Ciceri F; Huang H; Mohty M; Gorin NC
    Am J Hematol; 2024 Jul; 99(7):1290-1299. PubMed ID: 38654658
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pro-Inflammatory Activation Suppresses TRAIL-induced Apoptosis of Acute Myeloid leukemia Cells.
    Kobyakova MI; Senotov AS; Krasnov KS; Lomovskaya YV; Odinokova IV; Kolotova AA; Ermakov AM; Zvyagina AI; Fadeeva IS; Fetisova EI; Akatov VS; Fadeev RS
    Biochemistry (Mosc); 2024 Mar; 89(3):431-440. PubMed ID: 38648763
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity.
    Locke FL; Siddiqi T; Jacobson CA; Ghobadi A; Ahmed S; Miklos DB; Perales MA; Munoz J; Fingrut WB; Pennisi M; Gauthier J; Shadman M; Gowda L; Mirza AS; Abid MB; Hong S; Majhail NS; Kharfan-Dabaja MA; Khurana A; Badar T; Lin Y; Bennani NN; Herr MM; Hu ZH; Wang HL; Baer A; Baro E; Miao H; Spooner C; Xu H; Pasquini MC
    Blood; 2024 Jun; 143(26):2722-2734. PubMed ID: 38635762
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. White Blood Cell Count, Neutrophil-to-Lymphocyte Ratio, and Incident Cancer in the UK Biobank.
    Song M; Graubard BI; Loftfield E; Rabkin CS; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2024 Jun; 33(6):821-829. PubMed ID: 38568024
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
    Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
    [No Abstract]    [Full Text] [Related]  

  • 14. A Study on Geographic Correlation between Indoor Radon Exposure and leukemia Incidence in Canada.
    Chen J
    Health Phys; 2024 May; 126(5):315-321. PubMed ID: 38526250
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Childbirth rates in women with myeloproliferative neoplasms.
    Landtblom AR; Andersson TM; Johansson ALV; Lundberg FE; Samuelsson J; Björkholm M; Hultcrantz M
    Leukemia; 2024 May; 38(5):1081-1085. PubMed ID: 38461191
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. First complete remission favours haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia.
    Jo T; Ueda T; Akahoshi Y; Kondo T; Uchida N; Tanaka M; Nakamae H; Doki N; Ota S; Sawa M; Ohigashi H; Maruyama Y; Takayama N; Nishida T; Hiramoto N; Katayama Y; Kanda Y; Ichinohe T; Atsuta Y; Arai Y;
    Br J Haematol; 2024 May; 204(5):1913-1919. PubMed ID: 38420726
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Immune Reconstitution after BTKi Treatment in Chronic Lymphocytic leukemia].
    Wang YL; Tang PX; Chen KL; Guo GY; Long JL; Zou YQ; Liang HY; Xu ZS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):1-5. PubMed ID: 38387891
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Chronic Lymphocytic leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.
    Grants JM; May C; Bridgers J; Huang S; Gillis S; Meissner B; Boyle M; Ben-Neriah S; Hung S; Duns G; Hilton L; Gerrie AS; Marra M; Kridel R; Sabatini PJB; Steidl C; Scott DW; Karsan A
    Clin Chem; 2024 Jan; 70(1):273-284. PubMed ID: 38175592
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic leukemia: Focus on the Genes Involved.
    Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax.
    Jain N; Croner LJ; Allan JN; Siddiqi T; Tedeschi A; Badoux XC; Eckert K; Cheung LWK; Mukherjee A; Dean JP; Szafer-Glusman E; Seymour JF
    Clin Cancer Res; 2024 Feb; 30(3):498-505. PubMed ID: 37955424
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 27.